ABOUT COREPHARMA
Founded in 1998, CorePharma is a “Quality Driven + People Powered” U.S.-based Oral Solid Dosage CDMO with a strong compliance track record. We provide clients with comprehensive end-to-end solutions from development through commercial launch backed by industry-leading customer service. Our state-of-the-art development, analytical, manufacturing, and packaging facilities meet the highest quality standards, with a total capacity of 5 billion dosage units annually. In 2025, CorePharma expanded its operations with the opening of its fifth facility, a dedicated Hormone Suite designed to support specialized hormonal product development and manufacturing. CorePharma continues to invest in advanced technologies and capabilities including Spray Dry Dispersion, Roller Compaction, and other advanced Oral Solid Dosage technologies serving as your trusted, one-stop partner for all CDMO needs.
INDUSTRY INSIGHTS
-
![pharma-cdmo-GettyImages-2183428951]( "How Proactive Regulatory Planning Supports Improved Drug Formulation And Manufacture")
Integrating regulatory strategy with R&D planning early in drug development helps to minimize formulation risks and align manufacturing with compliance while preventing costly delays.
CONTACT INFORMATION
CorePharma
215 Wood Ave
Middlesex, NJ 08846
UNITED STATES
Phone: 908-752-5485
Contact: Evan Rafanello, VP of business development
SOLUTIONS
-
![pharma-cmo-GettyImages-2193955683]( "Why CorePharma?")
End-to-end pharma manufacturing support unites development expertise and scalable production to accelerate the path from formulation to commercial supply with quality and flexibility.
-
![drug-manufacturing-GettyImages-1405590436]( "Quality Drive + People Powered")
An integrated development and manufacturing approach that cuts handoffs, manages risk, and accelerates timelines by uniting formulation, analytics, production, and packaging.
